A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
The Evolution of Spinal Stability: Medtronic’s Infuse™ Bone Graft Receives FDA Approval for TLIF on September 28, 2026 Posted by
The Intersection of GLP-1 Medications and Sleep Apnea: A Comprehensive Guide to Treatment and Coverage on September 28, 2026 Posted by
Advancing the Frontier of Pain Management: Dr. Ball Achieves Medidata Certification on September 28, 2026 Posted by
A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
Posted in Medical Innovations FDA Advisory Panel Casts Doubt on Deramiocel: A Critical Juncture for Duchenne Muscular Dystrophy Treatment on July 30, 2026
Posted in Medical Innovations The Fragility of Hope: Inside the FDA’s Contentious Advisory Panel on Capricor’s Duchenne Therapy on July 30, 2026
Posted in Respiratory Health Breakthrough in Genetic Medicine: HOPE-3 Trial Results Offer New Hope for Advanced Duchenne Muscular Dystrophy on July 29, 2026
Posted in Medical Innovations The Regulatory Pivot: Regenxbio’s Bold Bet on Duchenne Gene Therapy Amidst FDA Leadership Flux on June 24, 2026
Posted in Medical Innovations Navigating Uncertainty: Regenxbio Faces Regulatory Crossroads for Duchenne Gene Therapy RGX-202 on May 15, 2026 rifanmuazin
Posted in Digital Health Tools Biotech Turmoil: Capricor Therapeutics Files Suit Against Partner Over Duchenne Therapy Launch on May 10, 2026 rifanmuazin
Posted in Medical Innovations Entrada Therapeutics Faces Investor Skepticism Following Latest Duchenne Muscular Dystrophy Data on May 10, 2026 rifanmuazin
Posted in Digital Health Tools Legal Showdown: Capricor Therapeutics Sues Partner Over “Fatal Flaw” in Duchenne Therapy Rollout on May 9, 2026 rifanmuazin
